Can the industry elevate the success rate of cancer trials?
Outsourcing Pharma
JUNE 7, 2022
During the upcoming BIO International Convention, experts from CerFlux, the MD Anderson Cancer Center, and Aga Khan University will weigh in with insights.
Tue.Jun 07, 2022
111 
Simple ways to support a presenter and benefit from their talk
pharmaphorum
JUNE 7, 2022
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post makes a case for encouraging and supporting presenters in order to get the most out of their expertise. Has this happened to you, too?
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
New ClinOne executive pursuing lifelong interest in human health
Outsourcing Pharma
JUNE 7, 2022
Former Medable vice president Brian Ongioni has joined the trial tech provider as vice president of product, continuing a quest for patient-focused solutions.
Redefining the approach to cancer care – a mission to improve patient outcomes
pharmaphorum
JUNE 7, 2022
Each year across Europe, 3.7 million people are diagnosed with a form of cancer, resulting in 1.9 million deaths, making cancer the second largest cause of mortality. Although Europe comprises only one eighth of the global population, cancer cases in the region make up a quarter of the world’s total. For a region that often pioneers medical and scientific breakthroughs, these statistics are not only shocking, but unacceptable.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Informa Connect 2022 Events
Pharma Marketing Network
JUNE 7, 2022
Upcoming Informa Connect Events: Hub and Specialty Pharmacy Models East – June 28-30, 2022. PAP – Patient Assistance & Access Programs – June 28-30, 2022. Transparency, Aggregate Spend & HCP Engagement – August 9-11, 2022. IDN & Bio/Pharma Partnering Summit – August 16-17, 2022. 18th Annual Pharma Forum – September 11-14, 2022.
Biogen bolsters pipeline again with Alectos deal
pharmaphorum
JUNE 7, 2022
Biogen has added a preclinical-stage drug candidate for Parkinson’s disease via a $722.5 million licensing agreement with Alectos Therapeutic, as it continues to rebuild a pipeline behind its side-lined Alzheimer’s therapy Aduhelm. The deal includes a $15 million upfront payment that gives Biogen global rights to selective GBA2 inhibitor AL01811, which it says has the potential to become a first-in-class oral therapy for Parkinson’s that could strike at the pathological mechani
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Combination pricing: access to the future of oncology treatment relies on collaboration
pharmaphorum
JUNE 7, 2022
Combination therapies are fast becoming the cornerstone of cancer treatment: not just in the UK, but across the world. With strong evidence to support how two or more medicines can work simultaneously to target different pathways in numerous ways, it’s clear that these kinds of treatments are vital in helping to change the way people live with complex diseases like cancer.
Bachem and Eli Lilly link up to advance oligonucleotide products
Pharma Times
JUNE 7, 2022
The agreement will see the two companies expand current oligonucleotide technologies
AI specialist Insilico raises $60m as more projects head to clinic
pharmaphorum
JUNE 7, 2022
Insilico Medicine has raised $60 million in fourth-round financing that will help to fund the advancement of more drugs towards the clinical testing stage. The Hong Kong-based startup – one of an emerging crop of companies which are using artificial intelligence platforms to discover and design new therapeutic compounds – took its first drug into clinical trials in February.
June is National Safety Month
OctariusRx
JUNE 7, 2022
June is National Safety Month and at OctariusRx we recognize and support the National Safety Council’s efforts to build and advocate for a culture of safety. When it comes to safety, too much is never enough. Our team of consultant pharmacists works tirelessly to ensure our clients and patients are always as safe as possible. From our relentless focus on safe medication management, to guidance on workplace safety, we strive daily to develop and support a culture that leads to safety, regulatory
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Let's personalize your content